Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.eprac.2021.07.008 http://scihub22266oqcxt.onion/10.1016/j.eprac.2021.07.008 34284145!8286241!34284145     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34284145&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Endocr+Pract 2021 ; 27 (10): 1046-1051 Nephropedia Template TP {{tp|p=34284145|t=2021. Correlation of Hemoglobin A1C and Outcomes in Patients Hospitalized With COVID-19 |pdf=|usr=}}{{34284145}} gab.com Text Correlation of Hemoglobin A1C and Outcomes in Patients Hospitalized With COVID-19 JO: Endocr Pract http://www.kidney.de/pget.php?&tw=1&pmid=34284145 #FOAvip OBJECTIVE: Diabetes is a known risk factor for severe coronavirus disease 2019 (COVID-19). We conducted this study to determine if there is a correlation between hemoglobin A1C (HbA1C) level and poor outcomes in hospitalized patients with diabetes and COVID-19. METHODS: This is a retrospective, single-center, observational study of patients with diabetes (defined by an HbA1C level of >/=6.5% or known medical history of diabetes) who had a confirmed case of COVID-19 and required hospitalization. All patients were admitted to our institution between March 3, 2020, and May 5, 2020. HbA1C results for each patient were divided into quartiles: 5.1% to 6.7% (32-50 mmol/mol), 6.8% to 7.5% (51-58 mmol/mol), 7.6% to 8.9% (60-74 mmol/mol), and >9% (>75 mmol/mol). The primary outcome was in-hospital mortality. Secondary outcomes included admission to an intensive care unit, invasive mechanical ventilation, acute kidney injury, acute thrombosis, and length of hospital stay. RESULTS: A total of 506 patients were included. The number of deaths within quartiles 1 through 4 were 30 (25%), 37 (27%), 34 (27%), and 24 (19%), respectively. There was no statistical difference in the primary or secondary outcomes among the quartiles, except that acute kidney injury was less frequent in quartile 4. CONCLUSION: There was no significant association between HbA1C level and adverse clinical outcomes in patients with diabetes who are hospitalized with COVID-19. HbA1C levels should not be used for risk stratification in these patients. Twit Text FOAVip Correlation of Hemoglobin A1C and Outcomes in Patients Hospitalized With COVID-19 ????Endocr Pract http://www.kidney.de/pget.php?&tw=1&pmid=34284145 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34284145 #FOAvip English Wikipedia <ref>{{Cite pmid|34284145}}</ref> Correlation of Hemoglobin A1C and Outcomes in Patients Hospitalized With COVID-19 #MMPMID34284145 Patel AJ; Klek SP; Peragallo-Dittko V; Goldstein M; Burdge E; Nadile V; Ramadhar J; Islam S; Rothberger GD Endocr Pract 2021[Oct]; 27 (10): 1046-1051 PMID34284145show ga OBJECTIVE: Diabetes is a known risk factor for severe coronavirus disease 2019 (COVID-19). We conducted this study to determine if there is a correlation between hemoglobin A1C (HbA1C) level and poor outcomes in hospitalized patients with diabetes and COVID-19. METHODS: This is a retrospective, single-center, observational study of patients with diabetes (defined by an HbA1C level of >/=6.5% or known medical history of diabetes) who had a confirmed case of COVID-19 and required hospitalization. All patients were admitted to our institution between March 3, 2020, and May 5, 2020. HbA1C results for each patient were divided into quartiles: 5.1% to 6.7% (32-50 mmol/mol), 6.8% to 7.5% (51-58 mmol/mol), 7.6% to 8.9% (60-74 mmol/mol), and >9% (>75 mmol/mol). The primary outcome was in-hospital mortality. Secondary outcomes included admission to an intensive care unit, invasive mechanical ventilation, acute kidney injury, acute thrombosis, and length of hospital stay. RESULTS: A total of 506 patients were included. The number of deaths within quartiles 1 through 4 were 30 (25%), 37 (27%), 34 (27%), and 24 (19%), respectively. There was no statistical difference in the primary or secondary outcomes among the quartiles, except that acute kidney injury was less frequent in quartile 4. CONCLUSION: There was no significant association between HbA1C level and adverse clinical outcomes in patients with diabetes who are hospitalized with COVID-19. HbA1C levels should not be used for risk stratification in these patients. |*COVID-19/complications[MESH] |*Diabetes Mellitus/epidemiology/virology[MESH] |Glycated Hemoglobin/*analysis[MESH] |Hospital Mortality[MESH] |Hospitalization[MESH] |Humans[MESH]Correlation of Hemoglobin A1C and Outcomes in Patients Hospitalized Wi(epmc).pdf DeepDyve Pubget Overpricing